General Archive
-
BlogsWe must confront this silent pandemic as a global collective
Antimicrobial resistance (AMR) is often called the silent pandemic but for those of us working in this space, we are…
-
News releasesPACE announces £6 million funding for antibacterial treatment innovations to fill critical gap in R&D pipeline
PACE (Pathways to Antimicrobial Clinical Efficacy) launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections…
-
News releases3 steps LifeArc is taking to tackle antimicrobial resistance before it’s too late
Antimicrobial resistance (AMR) is one of the most urgent public health challenges of our time, threatening not only human health…
-
News releasesTackling antimicrobial resistance: LifeArc partners with the University of Cape Town to launch a new Centre for Translational AMR Research
LifeArc has announced a significant £5 million investment to co-establish a new Centre for Translational AMR Research (CTAR) Programme at…
-
News releasesGlobal AMR challenge receives a £5m boost to drive diagnostics innovation
PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its second funding round with up to £5 million available to support…
-
News releasesLifeArc becomes founding partner of new Fleming Initiative to tackle global threat of antimicrobial resistance
LifeArc has joined the Fleming Initiative as a founding partner alongside Cepheid and Optum, contributing to the initiative reaching a…
-
News releasesFirst awardees of £3m collaborative Drug Discovery Programme are announced
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has announced the first cohort of awardees of its Collaborative Discovery Programme…
-
News releasesLifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR)
LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR), which was published today, highlighting the desperate need…